...
首页> 外文期刊>Journal of Medicinal Chemistry >Thieno(3,2-b)- and thieno(2,3-b)pyrrole bioisosteric analogues of the hallucinogen and serotonin agonist N,N-dimethyltryptamine.
【24h】

Thieno(3,2-b)- and thieno(2,3-b)pyrrole bioisosteric analogues of the hallucinogen and serotonin agonist N,N-dimethyltryptamine.

机译:致幻剂和5-羟色胺激动剂N,N-二甲基色胺的硫代诺(3,2-b)-和硫代诺(2,3-b)吡咯生物立体异构体。

获取原文
获取原文并翻译 | 示例

摘要

The synthesis and biological activity of 6-[2-(N, N-dimethylamino)ethyl]-4H-thieno[3,2-b]pyrrole (3a) and 4-[2-(N, N-dimethylamino)ethyl]-6H-thieno[2,3-b]pyrrole (3b), thienopyrroles as potential bioisosteres of N,N-dimethyltryptamine (1a), are reported. Hallucinogen-like activity was evaluated in the two-lever drug discrimination paradigm using LSD- and DOI-trained rats. Neither 3a nor 3b substituted for LSD or DOI up to doses of 50 micromol/kg. By comparison, 1a fully substituted in LSD-trained rats. However, 3a and 3b fully substituted for the 5-HT1A agonist LY293284 ((-)-(4R)-6-acetyl-4-(di-n-propylamino)-1,3,4, 5-tetrahydrobenz[c,d]indole). Both 3a and 3b induced a brief "serotonin syndrome" and salivation, an indication of 5-HT1A receptor activation. At the cloned human 5-HT2A receptor 3b had about twice the affinity of 3a. At the cloned human 5-HT2B and 5-HT2C receptors, however, 3a had about twice the affinity of 3b. Therefore, thiophene lacks equivalence as a replacement for the phenyl ring in the indole nucleus of tryptamines that bind to 5-HT2 receptor subtypes and possess LSD-like behavioral effects. Whereas both of the thienopyrroles had lower affinity than the corresponding 1a at 5-HT2 receptors, 3a and 3b had significantly greater affinity than 1a at the 5-HT1A receptor. Thus, thienopyrrole does appear to serve as a potent bioisostere for the indole nucleus in compounds that bind to the serotonin 5-HT1A receptor. These differences in biological activity suggest that serotonin receptor isoforms are very sensitive to subtle changes in the electronic character of the aromatic systems of indole compounds.
机译:6- [2-(N,N-二甲基氨基)乙基] -4H-噻吩并[3,2-b]吡咯(3a)和4- [2-(N,N-二甲基氨基)乙基]的合成及生物活性据报道,-6H-噻吩并[2,3-b]吡咯(3b)是潜在的N,N-二甲基色胺(1a)的生物异构体。在使用LSD和DOI训练的大鼠的两杆药物歧视范例中评估了致幻剂样活性。 3a和3b都不能代替LSD或DOI达到50 micromol / kg的剂量。相比之下,在接受LSD训练的大鼠中1a被完全取代。然而,3a和3b完全取代了5-HT1A激动剂LY293284((-)-(4R)-6-乙酰基-4-(di-n-丙基氨基)-1,3,4,5-四氢苯并[c,d ]吲哚)。 3a和3b均引起短暂的“ 5-羟色胺综合征”和流涎,这是5-HT1A受体激活的指示。在克隆的人5-HT2A受体3b具有约3a亲和力的两倍。但是,在克隆的人5-HT2B和5-HT2C受体上,3a的亲和力约为3b的两倍。因此,噻吩在取代与5-HT 2受体亚型结合并具有类似于LSD的行为作用的色胺的吲哚核中取代苯环时缺乏等效性。尽管两种噻吩并吡咯在5-HT2受体上的亲和力均低于相应的1a,但3a和3b在5-HT1A受体上的亲和力均明显高于1a。因此,在与5-羟色胺5-HT1A受体结合的化合物中,噻吩并吡咯确实充当了吲哚核的有效生物同工异构体。这些生物学活性上的差异表明,血清素受体同工型对吲哚化合物芳族系统电子特性的细微变化非常敏感。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号